Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Olmesartan medoxomil/hydchlorothiazide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tab
0205052Y0AAAAAA
|
Olmesartan medoxomil/hydchlorothiazide | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 2,162 |
|
Olmesartan medoxomil 40mg / Hydrochlorothiazide 12.5mg tab
0205052Y0AAACAC
|
Olmesartan medoxomil/hydchlorothiazide | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 1,380 |
|
Olmesartan medoxomil 20mg / Hydrochlorothiazide 25mg tablets
0205052Y0AAABAB
|
Olmesartan medoxomil/hydchlorothiazide | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 558 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.